Apellis Pharmaceuticals, Inc. Return On Assets in % from Q2 2018 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Apellis Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2018 to Q3 2025.
  • Apellis Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2025 was 5.04 %.
  • Apellis Pharmaceuticals, Inc. annual Return On Assets for 2024 was -22.5 %, a 62.8% increase from 2023.
  • Apellis Pharmaceuticals, Inc. annual Return On Assets for 2023 was -60.4 %, a 12.5% increase from 2022.
  • Apellis Pharmaceuticals, Inc. annual Return On Assets for 2022 was -69 %, a 32.6% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)

Apellis Pharmaceuticals, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 5.04 +34.2 Jul 1, 2025 Sep 30, 2025
Q2 2025 -26.7 +13.1 +32.9% Apr 1, 2025 Jun 30, 2025
Q1 2025 -25.6 +24.2 +48.6% Jan 1, 2025 Mar 31, 2025
Q4 2024 -22.5 +37.9 +62.8% Oct 1, 2024 Dec 31, 2024
Q3 2024 -29.2 +40.6 +58.2% Jul 1, 2024 Sep 30, 2024
Q2 2024 -39.8 +34.7 +46.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -49.8 +26.7 +34.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -60.4 +8.6 +12.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -69.8 -4.82 -7.42% Jul 1, 2023 Sep 30, 2023
Q2 2023 -74.5 -2.69 -3.75% Apr 1, 2023 Jun 30, 2023
Q1 2023 -76.5 +9.8 +11.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -69 +33.3 +32.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -65 +4.45 +6.41% Jul 1, 2022 Sep 30, 2022
Q2 2022 -71.8 -15 -26.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -86.3 -44.1 -104% Jan 1, 2022 Mar 31, 2022
Q4 2021 -102 -60.4 -144% Oct 1, 2021 Dec 31, 2021
Q3 2021 -69.4 +9.53 +12.1% Jul 1, 2021 Sep 30, 2021
Q2 2021 -56.8 +21.1 +27.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -42.2 +48.7 +53.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -42 +39.8 +48.7% Oct 1, 2020 Dec 31, 2020
Q3 2020 -79 -9.1 -13% Jul 1, 2020 Sep 30, 2020
Q2 2020 -77.9 -5.9 -8.19% Apr 1, 2020 Jun 30, 2020
Q1 2020 -90.9 -30.1 -49.4% Jan 1, 2020 Mar 31, 2020
Q4 2019 -81.8 -23.3 -39.9% Oct 1, 2019 Dec 31, 2019
Q3 2019 -69.9 -18.5 -36.1% Jul 1, 2019 Sep 30, 2019
Q2 2019 -72 -18.2 -33.9% Apr 1, 2019 Jun 30, 2019
Q1 2019 -60.8 Jan 1, 2019 Mar 31, 2019
Q4 2018 -58.4 Oct 1, 2018 Dec 31, 2018
Q3 2018 -51.4 Jul 1, 2018 Sep 30, 2018
Q2 2018 -53.8 Apr 1, 2018 Jun 30, 2018

Apellis Pharmaceuticals, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -22.5 +37.9 +62.8% Jan 1, 2024 Dec 31, 2024
2023 -60.4 +8.6 +12.5% Jan 1, 2023 Dec 31, 2023
2022 -69 +33.3 +32.6% Jan 1, 2022 Dec 31, 2022
2021 -102 -60.4 -144% Jan 1, 2021 Dec 31, 2021
2020 -42 +39.8 +48.7% Jan 1, 2020 Dec 31, 2020
2019 -81.8 -23.3 -39.9% Jan 1, 2019 Dec 31, 2019
2018 -58.4 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.